Atlas Trials

A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients

Clinical trial NCT03284242 · COMPLETED

Trial details

NCT number
NCT03284242
Sponsor
Roberto Gedaly
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
End Stage Renal DiseaseKidney Transplant
Start date
2019-03-15
Primary completion
2024-04-10
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.